Saturday 17 October 2026
Export INMD’s income statement to Excel — free account
InMode Ltd.
INMD Healthcare Medical Devices
InMode Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $370.5 million, down 6.16% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 31.0% and free cash flow fell 12.6%, each against the same quarter a year earlier.
14.16
0.16
−1.12%
Follow INMD
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | 7 | 5 | 7 | 4 | 4 | 4 | 4 |
P/E ratio |
10.66 | 10.66 | 18.95 | 23.27 | 35.11 | 17.99 | 9.34 | 7.05 | 10.06 |
Altman Z-Score |
— | — | 21.03 | 28.84 | 58.90 | 23.49 | 18.21 | 13.23 | 10.45 |
P/S ratio |
2.96 | 2.96 | 7.33 | 8.31 | 16.08 | 6.40 | 3.77 | 3.35 | 2.56 |
P/FCF ratio |
9.81 | 9.81 | 18.63 | 21.74 | 33.05 | 16.16 | 10.54 | 10.03 | 11.26 |
Altman Z″-Score (non-manufacturers) |
7.38 | 8.47 | 13.56 | 15.82 | 17.32 | 16.63 | 20.97 | 19.00 | 18.86 |
Beneish M-Score |
— | (2.87) | (2.25) | (2.22) | (1.58) | (2.28) | (1.93) | (0.67) | (2.25) |
P/Operating CF |
19.79 | 19.79 | 41.79 | 41.17 | 108.68 | 50.89 | 30.29 | 40.82 | 41.87 |
P/B ratio |
6.62 | 6.62 | 6.37 | 6.70 | 13.82 | 5.24 | 2.36 | 1.88 | 1.39 |
Price to Tangible BV |
6.62 | 6.62 | 6.37 | 6.70 | 13.82 | 5.24 | 2.36 | 1.88 | 1.39 |
EV/Sales |
2.29 | 2.29 | 6.09 | 7.04 | 14.91 | 5.20 | 2.27 | 1.84 | 1.06 |
EV/EBITDA |
7.96 | 7.96 | 15.90 | 19.81 | 31.74 | 11.89 | 5.68 | 6.43 | 4.58 |
EV/Operating CF |
7.47 | 7.47 | 15.31 | 18.32 | 30.49 | 13.00 | 6.30 | 5.49 | 4.62 |
EV/FCF |
7.59 | 7.59 | 15.48 | 18.43 | 30.66 | 13.12 | 6.33 | 5.51 | 4.68 |
Quick Ratio |
2.39 | 2.41 | 6.27 | 7.84 | 8.66 | 7.19 | 12.48 | 9.38 | 8.83 |
Current Ratio |
2.76 | 2.64 | 6.56 | 8.27 | 9.07 | 7.67 | 13.18 | 10.23 | 9.88 |
Net Debt/EBITDA |
(2.74) | (2.59) | (3.23) | (3.56) | (2.48) | (2.76) | (3.78) | (5.27) | (6.45) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.89 | 1.66 | 1.04 | 0.80 | 0.92 | 0.81 | 0.65 | 0.48 | 0.48 |
Operating CF/Net income |
1.66 | 1.65 | 1.02 | 1.06 | 1.06 | 1.12 | 0.89 | 0.73 | 0.91 |
Capex/Depreciation |
(0.93) | (2.07) | (2.29) | (1.11) | (1.82) | (2.32) | (1.13) | (0.92) | (1.40) |
| 28.12% | 69.77% | 54.48% | 34.47% | 49.15% | 33.29% | 29.50% | 24.31% | 13.53% | |
| 14.64% | 37.13% | 40.84% | 29.19% | 42.61% | 28.77% | 26.25% | 21.99% | 12.09% | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1,709.17% | 267.20% | 65.52% | 41.74% |
Return on Tangible Assets |
36.68% | 45.77% | 33.66% | 29.36% | 39.31% | 29.39% | 25.26% | 28.02% | 14.88% |
Average Days of Receivables |
48.30 | 34.63 | 24.37 | 24.92 | 33.86 | 33.82 | 43.49 | 54.02 | 68.21 |
Research and Development Expense of Revenue |
4.82% | 4.17% | 3.64% | 4.59% | 2.67% | 2.74% | 2.73% | 3.33% | 3.59% |
Selling, General and Administrative Expense of Revenue |
61.50% | 49.36% | 45.28% | 45.10% | 35.73% | 37.53% | 41.11% | 48.48% | 51.89% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
4.56% | 1.94% | 1.00% | 6.23% | 3.35% | 5.38% | 4.80% | 4.20% | 3.00% |
Graham Net Nets |
0.18 | 0.18 | 0.15 | 0.15 | 0.07 | 0.19 | 0.41 | 0.48 | 0.65 |
Graham Number |
0.00 | 2.82 | 8.46 | 9.02 | 15.20 | 17.22 | 22.47 | 21.75 | 18.63 |
Earnings Yield |
9.38% | 9.38% | 5.28% | 4.30% | 2.85% | 5.56% | 10.71% | 14.19% | 9.94% |
Free Cash Flow Yield |
10.19% | 10.19% | 5.37% | 4.60% | 3.03% | 6.19% | 9.49% | 9.97% | 8.88% |
Revenue per Share |
1.02 | 1.88 | 2.67 | 2.86 | 4.39 | 5.51 | 5.89 | 4.98 | 5.73 |
Operating CF per Share |
0.28 | 0.69 | 1.06 | 1.10 | 2.15 | 2.20 | 2.12 | 1.67 | 1.32 |
Capex per Share |
0.00 | (0.01) | (0.01) | (0.01) | (0.01) | (0.02) | (0.01) | (0.01) | (0.01) |
Free Cash Flow per Share |
0.27 | 0.69 | 1.05 | 1.09 | 2.14 | 2.18 | 2.11 | 1.66 | 1.30 |
Cash per Share |
0.48 | 1.15 | 3.31 | 3.61 | 5.11 | 6.64 | 8.88 | 7.52 | 8.59 |
Shareholders Equity per Share |
0.37 | 0.84 | 3.08 | 3.54 | 5.11 | 6.72 | 9.43 | 8.87 | 10.57 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.37 | 0.84 | 3.08 | 3.54 | 5.11 | 6.72 | 9.43 | 8.87 | 10.57 |
Free Cash Flow |
14.42 | 36.51 | 61.51 | 78.76 | 173.95 | 180.00 | 176.12 | 132.00 | 84.29 |
Working Capital |
23.69 | 48.34 | 180.71 | 254.56 | 418.26 | 547.35 | 781.19 | 644.60 | 627.88 |
Capital Expenditures |
(0.19) | (0.38) | (0.69) | (0.46) | (0.94) | (1.57) | (0.70) | (0.67) | (0.97) |
Net Current Asset Value |
17.16 | 41.38 | 174.63 | 249.31 | 407.38 | 539.58 | 769.42 | 632.60 | 615.39 |
EV/EBIT |
8.01 | 8.01 | 15.98 | 19.93 | 31.84 | 11.93 | 5.70 | 6.47 | 4.62 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
10.35 | 10.35 | 19.22 | 23.50 | 34.32 | 14.70 | 9.49 | 11.77 | 11.12 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.59 | 0.34 | 0.32 | 0.42 | 0.37 | 0.30 | 0.26 | 0.31 | 0.27 |
Cash ROIC |
32.41% | 34.45% | 16.48% | 15.26% | 20.91% | 16.33% | 11.52% | 10.15% | 6.81% |
Accounts Receivable Turnover |
6.45 | 12.08 | 15.68 | 16.82 | 15.14 | 12.07 | 9.77 | 6.75 | 5.80 |
Accounts Payable Turnover |
2.39 | 3.98 | 4.93 | 6.10 | 7.06 | 5.87 | 5.34 | 5.60 | 5.02 |
Inventory Turnover |
1.51 | 2.51 | 2.47 | 2.53 | 2.98 | 2.41 | 1.90 | 1.49 | 1.19 |
Average Days of Payables |
123.53 | 109.30 | 66.77 | 75.84 | 59.79 | 80.67 | 63.16 | 64.70 | 82.21 |
Days of Inventory on Hand |
203.00 | 168.79 | 169.68 | 177.28 | 143.20 | 198.17 | 203.94 | 279.54 | 339.87 |
Average Receivables |
8.29 | 8.29 | 9.97 | 12.26 | 23.62 | 37.63 | 50.36 | 58.53 | 63.83 |
Average Payables |
3.79 | 3.79 | 4.11 | 5.06 | 7.59 | 12.51 | 15.10 | 13.87 | 15.85 |
Average Inventory |
6.00 | 6.00 | 8.19 | 12.20 | 18.00 | 30.46 | 42.50 | 52.32 | 66.80 |
Average Assets |
60.25 | 60.25 | 149.72 | 257.07 | 387.15 | 561.48 | 753.85 | 824.48 | 776.05 |
Average Common Equity |
31.36 | 32.06 | 112.24 | 217.64 | 335.64 | 485.21 | 671.00 | 745.59 | 693.51 |
Columns are period end dates